The Institute for Healthcare Improvement (IHI), an independent not-for-profit organization based in Boston, Massachusetts, is a leading innovator, convener, partner, and driver of results in health and health care improvement worldwide. At our core, we believe everyone should get the best care and health possible. This passionate belief fuels our mission to improve health and health care.
Episodes
Thursday Aug 09, 2018
Thursday Aug 09, 2018
May 2008 Author in the Room® Teleconference
Authors: Barbara V. Howard, PhD, and W. James Howard, MD
Summary Points:
- Reducing LDL-C and SBP to lower targets resulted in regression of carotid atherosclerosis and decrease in LV mass in individuals with type 2 diabetes.
- Clinical event rate was low in both groups and did not differ longer term follow-up. It will be necessary to determine whether the aggressive targets result in favorable risks or benefits.
- More emphasis should be placed on reaching conventional targets for both LDL-C and SBP in diabetic patients.
- More trials are needed to evaluate targets for lipids and BP rather than specific treatment regimens.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.